Fermer le menu

 

Member of Lyonbiopole

 

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s portfolio of injectable treatments for diabetes, featuring five clinical-stage products and three preclinical products, is among the largest and most differentiated of the industry.

 

Strategic application domain: Human Medicine

Application market: Metabolic Disorders - Endocrinology, Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on dec. 22nd, 2005 - 125 employees

 

Address

115 avenue Lacassagne 69003 LYON

 

Contacts

Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.